ISRCTN36905484已完成不适用
Yellow fever vaccine dose-response study of 17-DD on children between 9 and 11 months of age: a double-blind randomised controlled trial
Bio-Manguinhos/Fiocruz (Brazil)0 个研究点目标入组 1,800 人开始时间: 2011年6月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Healthy children, aged 9 - 11 months old
- •2. Guardians agree to participate after reading and understanding free and informed consent form
排除标准
- •1. Prior vaccination against yellow fever
- •2. Use of immunosuppressor drugs in the last 12 months
- •3. Personal history of autoimmune diseases
- •4. Personal history of thymus diseases
- •5. Personal history of anaphylactic reactions to foods, drugs or vaccines
- •6. Personal history of allergy to eggs, erythromycin, canamycin or gelatin
- •7. Persons who received immunoglobulin, blood transfusions or blood derivatives in the last 12 months
- •8. Persons who received live virus vaccines in the last 30 days or who plan to receive them in the following 30 days after yellow fever vaccination
- •9. Acute febrile disease with an impaired general condition on time of vaccination
- •10. Metabolic diseases or metabolism inborn errors
- •11. Personal history of primary acquired immunodeficiency
- •12. Personal history of neoplasia (on treatment)
研究者
相似试验
已完成
不适用
Yellow fever vaccine dose-response studyYellow feverYellow fever vaccinationInfections and InfestationsISRCTN38082350Bio-Manguinhos/Fiocruz (Brazil)1,050
进行中（未招募）
不适用
Study of Yellow Fever Vaccine Administered With Sanofi Pasteur's Dengue Vaccine in Healthy Toddlers at 12-13 Months of Age in Colombia and PeruPrevention of symptomatic dengue diseaseEUCTR2014-001714-26-Outside-EU/EEASanofi Pasteur SA792
进行中（未招募）
不适用
Immunity of the Vaccine against Yellow Fever in patients taking medications that affect the immune systemnspecified rheumatoid arthritisM06.9RBR-946bv5Centro de Pesquisas René Rachou- FIOCRUZ
尚未招募
不适用
Immunity induced by yellow fever vaccination in the elderly (60yrs or older)travellergele koorts, oudere, reizen, neutraliserende antistoffen, bijwerkingenyellow fever, elderly, travel, neutralizing antibodies, adverse eventsNL-OMON20831A.H.E. Roukens en L.G. Visser60
已完成
不适用
Measurement of yellow fever vaccine efficacy; is 10 years the right point in time for revaccination?Yellow fever infection10047438NL-OMON39667Academisch Medisch Centrum119